Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 75,"Kurz SG, et al., Endocrinology. 2008 Apr 17",mammary gland integrity trait,,RS:0001158,ACI.COP-(D10Mgh8-D10Rat4)/Shul,female,259 days,3,,CMO:0000343,mammary tumor number,,,,0,,,,MMO:0000344,necropsy,,,,,,,control condition,11365,control condition 75,"Kurz SG, et al., Endocrinology. 2008 Apr 17",mammary gland integrity trait,,RS:0001158,ACI.COP-(D10Mgh8-D10Rat4)/Shul,female,259 days,12,,CMO:0000343,mammary tumor number,,,,4.8,,1.0392,3.6,MMO:0000344,necropsy,,,,,,,17 beta-estradiol (27.5 mg) (for 196 days),11366,17 beta-estradiol (27.5 mg) (for 196 days)